Small-Molecule Modulation of PPARs for the Treatment of Prevalent Vascular Retinal Diseases
Vascular-related retinal diseases dramatically impact quality of life and create a substantial burden on the healthcare system. Age-related macular degeneration, diabetic retinopathy, and retinopathy of prematurity are leading causes of irreversible blindness. In recent years, the scientific communi...
Main Authors: | Xiaozheng Dou, Adam S. Duerfeldt |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/23/9251 |
Similar Items
-
Targeting non-coding RNAs for the treatment of retinal diseases
by: Juhyun Song, et al.
Published: (2021-06-01) -
New insight into the role of the complement in the most common types of retinopathy-current literature review
by: Martyna Chrzanowska, et al.
Published: (2018-11-01) -
Effects of major ozonated autohemotherapy in the treatment of dry age related macular degeneration: a randomized controlled clinical study
by: Emma Borrell, et al.
Published: (2012-12-01) -
Evaluating peripheral retinal vascularization and rate of recurrence after intravitreal injection of ranibizumab as a primary treatment for retinopathy of prematurity
by: Mostafa M El Manhaly, et al.
Published: (2020-01-01) -
Prevalence, Pattern and Risk Factors of Retinal Diseases Among an Elderly Population in Nepal: The Bhaktapur Retina Study
by: Thapa R, et al.
Published: (2020-07-01)